Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00514878 · ClinicalTrials.gov registry record

Development of a Predictive Model for Post-Discharge Nausea and Vomiting (PDNV)

A clinical trial of Postoperative Pain and Nausea, sponsored by University of California, San Francisco.

Completed
Registry status
2,000
Enrollment target
1
Study location

NCT00514878 is a study of Postoperative Pain and Nausea that has completed, run by University of California, San Francisco. The registered enrollment target is 2,000 participants, above the 200-participant average among 63 other Postoperative Pain trials with a reported enrollment target (900% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00514878, a study of Postoperative Pain and Nausea, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this prospective cohort study is to develop a simplified risk model for post-discharge nausea and vomiting (PDNV) in adult same-day surgery patients in the US that will allow clinicians to identify those patients who would benefit from prophylactic antiemetic strategies.

Study Locations (1)

California

  • Perioperative Clinical Research Core, University of California - San Francisco

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2007-08
Est. Completion 2008-11

What the Registry Record Tells You About NCT00514878

The ClinicalTrials.gov registry entry for NCT00514878 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 200-participant average among 63 other Postoperative Pain trials with a reported enrollment target (900% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 0 interventions.

NCT00514878 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00514878 about?

NCT00514878 is a clinical study titled "Development of a Predictive Model for Post-Discharge Nausea and Vomiting (PDNV)". The primary purpose of this prospective cohort study is to develop a simplified risk model for post-discharge nausea and vomiting (PDNV) in adult same-day surgery patients in the US that will allow clinicians to identify those patients who would benefit from prophylactic antiemetic strategies.

What is the current status of trial NCT00514878?

This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2007-08. Estimated completion is 2008-11.

What conditions does trial NCT00514878 study?

This clinical trial studies the following conditions: Postoperative Pain, Nausea, Postoperative Nausea and Vomiting, Postdischarge Nausea and Vomiting.

Who is sponsoring clinical trial NCT00514878?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00514878 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.